Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Eribulin mesylate | 441045-17-6 | 99.3% | 826.00 | 10 MG
Supplier: Medchemexpress LLC 10MGHY13442A
Eribulin mesylate is a microtubule targeting agent designed for metastatic breast cancer research. It effectively inhibits the proliferation of cancer cells by binding to microtubule proteins and microtubules, demonstrating significant activity both in vitro and in vivo.
- Inhibits cell proliferation in various cancer cell lines.
- Induces early apoptosis and G2/M arrest in LM8 cells.
- Suppresses cell migration at low concentrations.
- Reduces primary tumor growth and lung metastasis in osteosarcoma models.
- Suppresses circulating tumor cells.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?